A range of respiratory illnesses including COVID-19 and influenza could be prevented and treated using a widely available generic antibiotic, the results of a new study revealed.
A team of researchers from Yale tested the effectiveness of antibiotic neomycin in animal models and found that administering the antibiotic neomycin through the nasal passage triggered a robust interferon-stimulated genes (ISG) line of defense against both SARS-CoV-2 and a highly virulent strain of influenza A virus. Also, administering neomycin intranasally significantly reduced the transmission of SARS-CoV-2 through contact in hamsters.
